BSX
Boston Scientific Corporation
Stock
$42.60−0.63 (−1.46%)Close Oct 2, 2026
- Revenue, 2025
- $20.1B
- YoY, 2025
- +19.9%
- 5-year CAGR
- +15.2%
- 10-year CAGR
- +9.5%
Revenue
Revenue by fiscal year
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $20.1B | +19.9% |
| 2024 | $16.7B | +17.6% |
| 2023 | $14.2B | +12.3% |
| 2022 | $12.7B | +6.7% |
| 2021 | $11.9B | +19.9% |
| 2020 | $9.9B | −7.7% |
| 2019 | $10.7B | +9.3% |
| 2018 | $9.8B | +8.6% |
| 2017 | $9.0B | −0.3% |
| 2016 | $9.1B | +12.5% |
| 2015 | $8.1B | +8.1% |
| 2014 | $7.5B | +5.5% |
| 2013 | $7.1B | −2.4% |
| 2012 | $7.2B | −4.9% |
| 2011 | $7.6B | −2.4% |
| 2010 | $7.8B | −4.7% |
| 2009 | $8.2B | +1.7% |
| 2008 | $8.1B | −3.7% |
| 2007 | $8.4B | — |